Drugs / Adoptive Cellular Therapy
last change Oct 2014 re-read 3 minutes ago

Adoptive Cellular Therapy

Cell therapy

Developed for
cytomegalovirus infection
Investigated by
BioAnaLab · Cell Medica Ltd · Commitum AB · EMAS Pharma · Wellcome Trust

Trials 1

20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT01077908 Jul 2008 → Sep 2014 cytomegalovirus infection Cell Medica Ltd Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Adoptive Cellular Therapy ClinicalTrials.gov intervention name — accepted as the source's own label NCT01077908 ↗
Modality Cell therapy “CMV-specific adoptive cellular therapy” NCT01077908 ↗